Camilla M. Grunewald

Head & Neck Surgery
Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Perioperative treatment of muscle-invasive bladder cancer : Current treatment concepts

Perioperative treatment of muscle-invasive bladder cancer : Current treatment concepts

Journal: Urologie (Heidelberg, Germany)

Published: January 07, 2026

Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma.

Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: June 16, 2025

Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology.

Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology.

Journal: Urology

Published: October 03, 2024

Can muscle invasive bladder cancer be treated without cystectomy in the future? : New data on trimodal therapy and bladder preservation after systemic therapy alone

Can muscle invasive bladder cancer be treated without cystectomy in the future? : New data on trimodal therapy and bladder preservation after systemic therapy alone

Journal: Urologie (Heidelberg, Germany)

Published: July 24, 2024

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 24, 2024

Neutropenia - when is GCSF support indicated?

Neutropenia - when is GCSF support indicated?

Journal: Aktuelle Urologie

Published: August 22, 2023

Epigenetic Priming and Development of New Combination Therapy Approaches.

Epigenetic Priming and Development of New Combination Therapy Approaches.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: July 06, 2023

BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.

BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.

Journal: Urologic oncology

Published: May 12, 2023

Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study.

Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study.

Journal: Scientific reports

Published: May 10, 2023

Using Circulating Tumor DNA To Guide Adjuvant Therapy in Bladder Cancer: IMvigor010 and IMvigor011.

Using Circulating Tumor DNA To Guide Adjuvant Therapy in Bladder Cancer: IMvigor010 and IMvigor011.

Journal: European urology focus

Published: March 01, 2022

Metastatic urothelial carcinoma-guideline-based therapy and new options

Metastatic urothelial carcinoma-guideline-based therapy and new options

Journal: Der Urologe. Ausg. A

Published: January 04, 2022

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells.

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells.

Journal: Frontiers in immunology

Published: September 24, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026